PALISADE BIO, INC.: 10-Q filed 2017-11-08
What PALISADE BIO, INC. reported in its quarterly report filed 2017-11-08 (fiscal Q3 2017): 34 published measures, 98 facts as tagged in accession 0001171843-17-006717.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-11-08
- Fiscal period
- fiscal Q3 2017
- Accession
- 0001171843-17-006717 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PALISADE BIO, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 16,188,766 | USD | |
| At 2016-12-31 | 22,604,328 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 4,623,990 | USD | |
| At 2016-12-31 | 11,273,550 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 11,564,776 | USD | |
| At 2016-12-31 | 11,330,778 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 9,063,710 | USD | |
| At 2016-12-31 | 15,194,949 | USD | |
| At 2016-09-30 | 5,676,129 | USD | |
| At 2015-12-31 | 4,716,533 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -133,783 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -12,350,229 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -5,220,283 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -15,678,575 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | -11,130,092 | USD | 273 |
| 2016-01-01 to 2016-09-30 | -11,535,750 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 10,993 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 98,088 | USD | 274 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 2,500 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 7,500 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 2,500 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 7,500 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 5,093,886 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 5,105,271 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | -93,638 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 7,389,182 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | -205,383,522 | USD | |
| At 2016-12-31 | -193,033,293 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 14,060,844 | shares | 92 |
| 2017-01-01 to 2017-09-30 | 12,380,054 | shares | 273 |
| 2016-07-01 to 2016-09-30 | 8,835,045 | shares | 92 |
| 2016-01-01 to 2016-09-30 | 8,019,153 | shares | 274 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 14,163,072 | shares | 92 |
| 2017-01-01 to 2017-09-30 | 12,380,054 | shares | 273 |
| 2016-07-01 to 2016-09-30 | 8,835,045 | shares | 92 |
| 2016-01-01 to 2016-09-30 | 8,019,153 | shares | 274 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -0.01 | USD/shares | 92 |
| 2017-01-01 to 2017-09-30 | -1 | USD/shares | 273 |
| 2016-07-01 to 2016-09-30 | -0.59 | USD/shares | 92 |
| 2016-01-01 to 2016-09-30 | -1.96 | USD/shares | 274 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -0.18 | USD/shares | 92 |
| 2017-01-01 to 2017-09-30 | -1 | USD/shares | 273 |
| 2016-07-01 to 2016-09-30 | -0.59 | USD/shares | 92 |
| 2016-01-01 to 2016-09-30 | -1.96 | USD/shares | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 196,191 | USD | |
| At 2016-12-31 | 269,557 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 1,504,143 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 2,866,773 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -2,587,873 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -11,038,111 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -4,917,005 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -14,984,886 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 14,707,225 | USD | |
| At 2016-12-31 | 20,904,716 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 1,383 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 155,843 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 240,462 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 949,375 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 1,834,727 | USD | |
| At 2016-12-31 | 7,333,424 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 37,458 | USD | |
| At 2016-12-31 | 10,491 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 2,590,373 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 11,045,611 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 4,919,505 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 14,992,386 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 1,383,863 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 6,871,028 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 3,589,793 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 9,130,012 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 15,146,027 | shares | |
| At 2016-12-31 | 11,032,858 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 216,784,493 | USD | |
| At 2016-12-31 | 204,239,837 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 2,345 | USD | |
| At 2016-12-31 | 3,905 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 915,457 | USD | |
| At 2016-12-31 | 990,153 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 13,719 | USD | |
| At 2016-12-31 | 15,662 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -134,788 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -12,351,789 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -5,220,262 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -15,677,059 | USD | 274 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -133,783 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -12,350,229 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -5,220,283 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -15,678,575 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 1,206,510 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 4,174,583 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 1,329,712 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 5,862,374 | USD | 274 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 2,454,090 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -1,312,118 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -303,278 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -693,689 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 26,967 | USD | 273 |
| 2016-01-01 to 2016-09-30 | -24,631 | USD | 274 |
Inspect the source
- Entity
- PALISADE BIO, INC. / CIK 0001357459
- Captured
- 2026-09-20T07:55:46.162Z
- SEC response SHA-256
1d4973c07aed8ad894103731546b55683b331acdd472b37e4b33a98a2f63a74c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001357459.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))